Delivery Order SPE2DB22D1106-SPE2DB24FFBR9
Award Date
7/12/24
Potential Completion Date
7/15/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,763.88 firm fixed-price delivery order is for the supply of 4566552120 buprenorphine-naloxone 8-2mg film in 30-count packages, with a completion date of November 27, 2024. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,521.84 firm fixed-price delivery order is for the supply of BUPRENORPHINE-NALOX 8-2MG FILM 30S, a medication used for the treatment of opioid use disorder. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,361.42 delivery order contract is for the supply of Buprenorphine-Nalox 8-2mg film, a medication used to treat opioid dependence. The contract has a completion date of May 18, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This contract award, valued at $1,006.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of buprenorphine-naloxone 8-2mg film, a medication used for the treatment of opioid dependence. The contract is a firm fixed-price delivery order with a completion date of October 31, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Buprenorphine-Nalox 8-2mg film in 30-count packages, a medication used in the treatment of opioid dependence. The contract has a ceiling value of $1,054.34 and an ultimate completion date of August 21, 2024. This contract is not a set-aside. AmerisourceBergen holds several large Indefinite Delivery Contracts (IDCs)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of a pharmaceutical product, Buprenorphine-Nalox 8-2mg Film 30s. The contract has a firm fixed price of $2,128.80 and a period of performance through May 10, 2024. Amerisourcebergen Drug Corp is a subsidiary of the larger Cencora, Inc. organization. This contract is not designated as a set-aside....
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,929.04 firm fixed price delivery order by the Defense Logistics Agency to supply 30 packages of buprenorphine-naloxone 4-1mg films for use by the Department of Defense. The single day contract, running from September 7-8, 2023, will be performed out of Amerisourcebergen's facility in Conshohocken, Pennsylvania and provides the opioid addiction treatment medication to support the DLA's medical...
This federal contract award, with an ID of SPE2DX15D3012|SPE2DX24F8HR0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Buprenorphine-Nalox 8-2mg film 30s, a pharmaceutical product, with a ceiling value of $2,080.38 and a completion date of February 5, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation....
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $912 to Amerisourcebergen Drug Corporation to supply 30 packages of 8-2mg Buprenorphine-Naloxone films. Performance will take place in Conshohocken, Pennsylvania under an indefinite delivery/indefinite quantity contract vehicle. As the DLA supports military treatment programs, this award will likely provide medication to address opioid use disorder among service members. Amerisourcebergen, a major...
The Defense Logistics Agency awarded a $376.07 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 units of 8-2mg Buprenorphine-Naloxone film. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is July 10-11, 2023. As the DLA supports military treatment and procurement programs, this contract for opioid addiction treatment medication will likely supply an on-base pharmacy. Amerisourcebergen, a subsidiary of...